Trial Shines Light on Questionable Benefits of Tocolytics for Preterm Birth

(MedPage Today) — AURORA, Colo. — Atosiban, an oxytocin receptor antagonist available in Europe, was not superior to placebo in improving neonatal outcomes for threatened preterm birth between 30 and 34 weeks’ gestation, according to the APOSTEL…